tradingkey.logo
tradingkey.logo
Search

Sotera Health Co

SHC
Add to Watchlist
17.380USD
0.0000.00%
Close 06/26, 16:00ETQuotes delayed by 15 min
4.96BMarket Cap
41.92P/E TTM

TradingKey Stock Score of Sotera Health Co

Currency: USD Updated: 2026-06-26

Key Insights

Sotera Health Co's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 7 out of 76 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 20.55.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sotera Health Co's Score

Industry at a Glance

Industry Ranking
7 / 76
Overall Ranking
38 / 4566
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Sotera Health Co Highlights

StrengthsRisks
Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.16B.
Undervalued
The company’s latest PE is 41.92, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 269.76M shares, increasing 7.15% quarter-over-quarter.
Held by David Einhorn
Star Investor David Einhorn holds 1.91M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.40.

Analyst Rating

Based on 11 analysts
Buy
Current Rating
20.545
Target Price
+20.15%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

How does TradingKey generate the Stock Score of Sotera Health Co?

The TradingKey Stock Score provides a comprehensive assessment of Sotera Health Co based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Sotera Health Co’s performance and outlook.

How do we generate the financial health score of Sotera Health Co?

To generate the financial health score of Sotera Health Co, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Sotera Health Co's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Sotera Health Co.

How do we generate the company valuation score of Sotera Health Co?

To generate the company valuation score of Sotera Health Co, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Sotera Health Co’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Sotera Health Co’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Sotera Health Co.

How do we generate the earnings forecast score of Sotera Health Co?

To calculate the earnings forecast score of Sotera Health Co, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Sotera Health Co’s future.

How do we generate the price momentum score of Sotera Health Co?

When generating the price momentum score for Sotera Health Co, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Sotera Health Co’s prices. A higher score indicates a more stable short-term price trend for Sotera Health Co.

How do we generate the institutional confidence score of Sotera Health Co?

To generate the institutional confidence score of Sotera Health Co, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Sotera Health Co’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Sotera Health Co.

How do we generate the risk management score of Sotera Health Co?

To assess the risk management score of Sotera Health Co, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Sotera Health Co’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Sotera Health Co.
KeyAI